Middle East Pharmaceutical Industries Company SJSC
SAU:4016
Decide at what price you'd be comfortable buying and we'll help you stay ready.
|
Johnson & Johnson
NYSE:JNJ
|
US |
|
Berkshire Hathaway Inc
NYSE:BRK.A
|
US |
|
Bank of America Corp
NYSE:BAC
|
US |
|
Mastercard Inc
NYSE:MA
|
US |
|
UnitedHealth Group Inc
NYSE:UNH
|
US |
|
Exxon Mobil Corp
NYSE:XOM
|
US |
|
Pfizer Inc
NYSE:PFE
|
US |
|
Nike Inc
NYSE:NKE
|
US |
|
Visa Inc
NYSE:V
|
US |
|
Alibaba Group Holding Ltd
NYSE:BABA
|
CN |
|
JPMorgan Chase & Co
NYSE:JPM
|
US |
|
Coca-Cola Co
NYSE:KO
|
US |
|
Verizon Communications Inc
NYSE:VZ
|
US |
|
Chevron Corp
NYSE:CVX
|
US |
|
Walt Disney Co
NYSE:DIS
|
US |
|
PayPal Holdings Inc
NASDAQ:PYPL
|
US |
Middle East Pharmaceutical Industries Company SJSC
Pre-Tax Income
Middle East Pharmaceutical Industries Company SJSC
Pre-Tax Income Peer Comparison
Competitors Analysis
Latest Figures & CAGR of Competitors
| Company | Pre-Tax Income | CAGR 3Y | CAGR 5Y | CAGR 10Y | ||
|---|---|---|---|---|---|---|
|
M
|
Middle East Pharmaceutical Industries Company SJSC
SAU:4016
|
Pre-Tax Income
﷼103.7m
|
CAGR 3-Years
17%
|
CAGR 5-Years
6%
|
CAGR 10-Years
N/A
|
|
|
Saudi Pharmaceutical Industries and Medical Appliances Corporation SJSC
SAU:2070
|
Pre-Tax Income
﷼205.7m
|
CAGR 3-Years
N/A
|
CAGR 5-Years
5%
|
CAGR 10-Years
-6%
|
|
|
J
|
Jamjoom Pharmaceuticals Factory Company SJSC
SAU:4015
|
Pre-Tax Income
﷼493.1m
|
CAGR 3-Years
38%
|
CAGR 5-Years
16%
|
CAGR 10-Years
N/A
|
|
Middle East Pharmaceutical Industries Company SJSC
Glance View
Middle East Pharmaceutical Industries Company SJSC is a SA-based company operating in Pharmaceuticals industry. The company is headquartered in Riyadh, Riyadh and currently employs 335 full-time employees. The company went IPO on 2024-02-27. Middle East Pharmaceutical Industries Company SJSC is a Saudi Arabia-based pharmaceutical company. The firm develops, manufactures, markets, and distributes a wide range of generic medicines and pharmaceuticals. The Company’s activity is the manufacture of disinfectants and sterilizers for medical devices and products, the manufacture of disinfectants and sterilizers for non-medical use, the manufacture of cosmetics, and the manufacture of pharmaceutical preparations for human use.
See Also
What is Middle East Pharmaceutical Industries Company SJSC's Pre-Tax Income?
Pre-Tax Income
103.7m
SAR
Based on the financial report for Dec 31, 2025, Middle East Pharmaceutical Industries Company SJSC's Pre-Tax Income amounts to 103.7m SAR.
What is Middle East Pharmaceutical Industries Company SJSC's Pre-Tax Income growth rate?
Pre-Tax Income CAGR 5Y
6%
Over the last year, the Pre-Tax Income growth was 20%. The average annual Pre-Tax Income growth rates for Middle East Pharmaceutical Industries Company SJSC have been 17% over the past three years , 6% over the past five years .
